Thomas H. Moll
Corporate Officer/Principal chez DMK PHARMACEUTICALS CORPORATION
Profil
Thomas H.
Moll is a professional with a doctorate degree from the University of Vienna.
He is currently the Vice President-Research at DMK Pharmaceuticals Corp.
Prior to this, he held the same position at Adamis Pharmaceuticals Corp.
from 2008 to 2009.
He also served as Vice President-Immunology at Cardion GmbH from 1998 to 2003 and Vice President-Research at Telos Pharmaceuticals LLC from 2003 to 2008.
In addition, he worked as an Assistant Professor at the University of Münster and was a member of The North American Vascular Biology Organization, The American Association of Immunologists, The American Society of Transplantation, and European Society of Gene & Cell Therapy.
He was also a Principal at Sandoz AG and Boehringer Ingelheim Chemicals, Inc.
Postes actifs de Thomas H. Moll
| Sociétés | Poste | Début |
|---|---|---|
| DMK PHARMACEUTICALS CORPORATION | Corporate Officer/Principal | 22/04/2009 |
Anciens postes connus de Thomas H. Moll
| Sociétés | Poste | Fin |
|---|---|---|
Adamis Pharmaceuticals Corp. /Old/
 Adamis Pharmaceuticals Corp. /Old/ Pharmaceuticals: MajorHealth Technology Adamis Pharmaceuticals Corp. manufactures and markets pharmaceutical products. It develops technology for the prevention of viral infections such as avian flu. It markets and sells prescription products for a variety of allergy, respiratory diseases, and pediatric conditions. The company was founded in June 2006 and is headquartered in San Deigo, CA. | Chief Tech/Sci/R&D Officer | 22/04/2009 |
| Telos Pharmaceuticals LLC | Chief Tech/Sci/R&D Officer | 01/01/2008 |
Cardion GmbH
 Cardion GmbH Medical SpecialtiesHealth Technology Cardion GmbH develops biopharmaceutical products. It integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products. The company is headquartered in Dusseldorf, Germany. | Corporate Officer/Principal | 01/01/2003 |
The North American Vascular Biology Organization
 The North American Vascular Biology Organization Miscellaneous Commercial ServicesCommercial Services The North American Vascular Biology Organization provides the forum for vascular biologists who are either in the traditional basic science disciplines or studying the pathogenesis and treatment of human disease. The firm focuses on focus on development, regeneration, endothelial and smooth muscle cell biology, stem/progenitor cells, cell signaling, vascular remodeling in disease, bioengineering, vascular matrix biology, inflammation, atherosclerosis, and hypertension. The company was founded in 1994 and is headquartered in Germantown, MD. | Corporate Officer/Principal | - |
| European Society of Gene & Cell Therapy | Corporate Officer/Principal | - |
Formation de Thomas H. Moll
| University of Vienna | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DMK PHARMACEUTICALS CORPORATION | Health Technology |
| Entreprise privées | 9 |
|---|---|
Adamis Pharmaceuticals Corp. /Old/
Adamis Pharmaceuticals Corp. /Old/ Pharmaceuticals: MajorHealth Technology Adamis Pharmaceuticals Corp. manufactures and markets pharmaceutical products. It develops technology for the prevention of viral infections such as avian flu. It markets and sells prescription products for a variety of allergy, respiratory diseases, and pediatric conditions. The company was founded in June 2006 and is headquartered in San Deigo, CA. | Health Technology |
Sandoz AG
 Sandoz AG Pharmaceuticals: GenericHealth Technology Part of Novartis AG, Sandoz AG is a Swiss company that develops generic medicines and biosimilars. The private company is based in Basel, Switzerland. | Health Technology |
Cardion GmbH
Cardion GmbH Medical SpecialtiesHealth Technology Cardion GmbH develops biopharmaceutical products. It integrates synergistic local gene delivery stem cell engineering and tolerance induction capabilities to build cardiovascular gene therapy products. The company is headquartered in Dusseldorf, Germany. | Health Technology |
Boehringer Ingelheim Chemicals, Inc.
 Boehringer Ingelheim Chemicals, Inc. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Chemicals, Inc. manufactures pharmaceutical ingredients and drug intermediates. It produces guaifenesin, methocarbamol, calcium polycarbophil, metoclopramide, doxapram, diacetone fructose, and methadone. The company was founded in 1976 and is headquartered in Petersburg, VA. | Health Technology |
The North American Vascular Biology Organization
The North American Vascular Biology Organization Miscellaneous Commercial ServicesCommercial Services The North American Vascular Biology Organization provides the forum for vascular biologists who are either in the traditional basic science disciplines or studying the pathogenesis and treatment of human disease. The firm focuses on focus on development, regeneration, endothelial and smooth muscle cell biology, stem/progenitor cells, cell signaling, vascular remodeling in disease, bioengineering, vascular matrix biology, inflammation, atherosclerosis, and hypertension. The company was founded in 1994 and is headquartered in Germantown, MD. | Commercial Services |
| The American Association of Immunologists | |
| Telos Pharmaceuticals LLC | |
The American Society of Transplantation
 The American Society of Transplantation Miscellaneous Commercial ServicesCommercial Services The American Society of Transplantation (AST) is a non-profit organization founded in 1982 that aims to advance the field of transplantation and improve patient care through research, education, advocacy, organ donation, and community service. The non-profit company is based in Mount Laurel, NJ. With over 4,000 professional members, AST is the largest transplant organization in the United States and is recognized as the premier society for transplantation. The society is sought out by other transplant organizations, policy makers, regulatory agencies, payors, academic institutions, and the general public for guidance, research, and resources related to transplantation. | Commercial Services |
| European Society of Gene & Cell Therapy |
